Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776922

CN1CCC(N(C)C(=O)CCc2cnoc2-c2ccc(F)cc2)C1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 7/20 0.43
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP3A4 P08684 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GRIN2B Q13224 1/20 0.36
CCR5 P51681 1/20 0.36
DPP4 P27487 3/20 0.36
DPP7 Q9UHL4 3/20 0.36
DPP8 Q6V1X1 2/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
POLB P06746 1/20 0.35
CHRM3 P20309 2/20 0.35
KCNH2 Q12809 1/20 0.34
DPP9 Q86TI2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776131 0.95 LMNA (0.42) MCHR1LMNAL3MBTL1CYP3A4MEN1
Trifluoroacetic Acid SCHEMBL5774584 0.87 MEN1 (0.44) MCHR1MEN1KMT2ACCR5CHRM3
Trifluoroacetic Acid SCHEMBL5773114 0.87 LMNA (0.41) MCHR1LMNAL3MBTL1CYP3A4KMT2A
Trifluoroacetic Acid SCHEMBL5772282 0.83 LMNA (0.39) MCHR1LMNAL3MBTL1CYP3A4KMT2A
Trifluoroacetic Acid SCHEMBL5773443 0.81 LMNA (0.41) MCHR1LMNAL3MBTL1CYP3A4MEN1
SCHEMBL5772900 0.80 BACE1 (0.46) LMNAL3MBTL1MEN1KMT2AGRIN2B
Trifluoroacetic Acid SCHEMBL5776834 0.78 HTT (0.46) LMNAKMT2ADPP7DPP8HDAC8
Trifluoroacetic Acid SCHEMBL5770496 0.77 HDAC4 (0.36) MCHR1GRIN2BDPP4DPP7DPP8
Trifluoroacetic Acid SCHEMBL5773674 0.77 OPRM1 (0.47) LMNACHRM3
Trifluoroacetic Acid SCHEMBL5776847 0.73 MDM2 (0.39) L3MBTL1MEN1KMT2ADPP7DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MCHR1 2026/4885LMNA 2770/4885L3MBTL1 2718/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MCHR1 2036/4885LMNA 2605/4885L3MBTL1 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.